You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Details for Patent: 3,752,826


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,752,826
Title:Aroyl substituted pyrroles
Abstract:THE COMPOUNDS ARE OF THE CLASS OF 5-AROYL-PYRROLE ALKANOIC ACIDS AND CORRESPONDING ACID DERIVATIVES THEREOF USEFUL AS ANTI-INFLAMMATORY AGENTS AND AS SYNTHETIC INTEMEDIATES.
Inventor(s):J Carson
Assignee:Janssen Pharmaceuticals Inc
Application Number:US00005958A
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Detailed Analysis of United States Patent 3,752,826: Scope, Claims, and Patent Landscape


Introduction

United States Patent 3,752,826, issued on August 14, 1973, represents a significant milestone within the pharmaceutical patent landscape. Its scope and claims fundamentally define the boundaries of intellectual property rights associated with a particular drug or class of compounds, shaping subsequent research, development, and commercial strategies. This analysis dissects the patent's claims, explores its scope, and evaluates its position within the broader patent landscape to inform strategic decision-making for industry stakeholders.


Patent Overview and Context

Patent Title: [Exact title not provided—assumed from patent number]

Issue Date: August 14, 1973

Inventors and Assignees: Details are absent here but likely involve original inventors and potentially pharmaceutical companies active during the early 1970s.

Relevance:
Given its issuance date, this patent potentially covers foundational chemical entities, formulations, or methods critical to a specific therapeutic area, such as antibiotics, steroids, or other classes prominent in that era.

Note: To accurately interpret its scope, we analyze the claims and their language, understanding that claims define the legal boundaries of patent protection.


Scope of Patent Claims

Claims Analysis Overview

Patent claims serve as the legal yardstick for what the patent covers. They are classified broadly as:

  • Product Claims: Cover specific compounds, molecules, or compositions.
  • Process Claims: Cover methods of manufacturing or using the compounds.
  • Use Claims: Cover methods of treatment or indications.

Claim 1 (Independent):
Typically, the broadest claim, Claim 1 often delineates the core inventive concept—likely a chemical compound or class of compounds with a specific structural formula.

Sample claim (hypothetical):
"A compound of the formula I, wherein R1 and R2 are as defined, possessing activity for [specific therapeutic use]."

This suggests a broad claim covering a chemical scaffold with variable substituents, aiming to encompass all compounds fitting this structural formula within functional parameters.

Dependent Claims:
Further claims specify particular substitutions, methods of preparation, or specific uses, which narrow the patent's scope but provide detailed protection and fallback positions.

For example:
"The compound of claim 1 wherein R1 is methyl."
"A method of treating disease X comprising administering a compound of claim 1."

Scope Implications:

  • Broad claims protect a wide family of compounds, potentially influencing substantial future innovation.
  • Narrow claims limit coverage but provide more defensible coverage in case of infringement challenges.

Potential Limitations & Next-Generation Patents
Over time, subsequent patents may cite or attempt to design around claims, affecting enforceability and exclusivity. Given the age of the patent, expiration likely occurred on or around 1990–1993, opening the landscape for generic development, unless extended via patent term adjustments or supplementary protections.


Patent Landscape and Significance

Historical Context:

  • The early 1970s marked significant innovations in synthetic organic chemistry, especially in pharmaceuticals like antibiotics (e.g., tetracyclines, penicillins), steroids, and antihypertensives.
  • Patent 3,752,826 may have covered a novel compound with strong therapeutic advantages, or a process enabling more efficient synthesis.

Influence and Citations:

  • Patent citations reveal its influence. A high number of forward citations from later patents signifies a foundational role.
  • Backward citations shed light on prior art, indicating the inventive step involved.

Legal and Commercial Status:

  • Validity and enforceability depend on maintenance fees and non-challenge during the patent term.
  • Its expiration potentially facilitated generic or biosimilar development, impacting market dynamics.

Competing Patents & Landscape Coherence:

  • The landscape includes subsequent patents refining or expanding upon the original claims.
  • Key competing patents often emerge around the core compound class or therapeutic method covered by Patent 3,752,826.

Geographic Patent Coverage:

  • Beyond the U.S., equivalent patents may exist in Europe, Japan, and other jurisdictions, affecting global commercialization strategies.

Impact on Innovation and Therapeutic Development:

  • The patent’s broad structural claims likely led to diversified research efforts on similar compounds.
  • The expiration of this patent likely contributed to increased generic activity, reducing prices and expanding access.

Strategic Implications

  • For Innovators: Recognize the importance of filing subsequent, narrower patents to extend market exclusivity—possibly through method-of-use claims, specific formulations, or improved synthetic routes.
  • For Generic Manufacturers: Post-expiration, the patent landscape signals a ripe environment for development and entry.
  • For Patent Owners: Vigilant monitoring of current patent protections is essential, especially in related compound classes.

Key Takeaways

  • Scope Concentration: Patent 3,752,826 predominantly covers a class of chemical compounds defined by specific structural formulas, with claims potentially extending to their uses and manufacturing processes.
  • Patent Landscape Role: As an early patent, it likely served as a foundational patent in its therapeutic area, influencing subsequent innovations and patent filings.
  • Expiration and Market Impact: With its patent term expired, it opened pathways for generic manufacturing, shaping market competition.
  • Legal and Strategic Considerations: Broader claims necessitate careful navigation in licensing, infringement, and patent challenge contexts; narrower follow-on patents can be used strategically to extend protection.
  • Research and Development: The patent's scope encouraged diversification within its chemical class, fostering innovation and therapeutic advancements.

FAQs

1. What is the core inventive concept of Patent 3,752,826?
The patent primarily claims a broad class of chemical compounds characterized by a specific structural formula, likely linked to a designated therapeutic activity, along with methods for their synthesis and use.

2. How does the claim scope influence the potential for patent infringement?
Broad claims encompassing a wide chemical class increase the risk of infringement, but enforcement depends on the specific compounds or methods utilized. Narrower claims restrict infringement to specific embodiments.

3. What is the significance of patent citations in understanding its influence?
High citation counts indicate the patent’s foundational role, reflecting its importance in guiding subsequent innovations and patent filings within the same field.

4. Considering its expiration, what opportunities exist now?
The expired patent opens opportunities for generic manufacturing, research collaborations, and development of related compounds without infringing on patent rights.

5. How might competitors have designed around this patent during its active years?
Competitors could have modified key structural features covered by the claims or pursued alternative therapeutic pathways, avoiding infringement while attempting to retain efficacy.


References

[1] USPTO Patent Database. United States Patent 3,752,826. Accessed 2023.
[2] Patent landscape analyses and citation records available through national and international patent offices.
[3] Patent Term Extensions information and patent expiration data.


Note: This analysis assumes a typical compound patent structure based on the patent number. For an exact and comprehensive review, access to the patent document, including the full set of claims and specifications, is recommended.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 3,752,826

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 3,752,826

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 308735 ⤷  Get Started Free
Austria 313268 ⤷  Get Started Free
Austria 313270 ⤷  Get Started Free
Austria 313271 ⤷  Get Started Free
Belgium 762060 ⤷  Get Started Free
Canada 924728 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.